赛马鲁肽
低血糖
医学
兴奋剂
艾塞那肽
胰高血糖素
不利影响
杜拉鲁肽
胰高血糖素样肽1受体
内科学
糖尿病
内分泌学
2型糖尿病
药理学
利拉鲁肽
胰岛素
受体
作者
Brian G. Wiener,Marlis Gnirke,Susi Vassallo,Silas W. Smith,Mark K. Su
标识
DOI:10.1080/15563650.2024.2322049
摘要
Prescriptions of semaglutide, a glucagon-like peptide-1 receptor agonist administered weekly for Type 2 diabetes mellitus and obesity, are increasing. Adverse effects from semaglutide overdose are poorly described. We report adverse effects from three unintentional semaglutide overdoses upon initiation.
科研通智能强力驱动
Strongly Powered by AbleSci AI